Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KPCXM18 Injection in Acute Ischemic Stroke
NCT05745311Phase 2Unknown
- Start
- Mar 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ginsenotriol disuccinate sodium in acute ischemic stroke (AIS). Status: unknown.
02
Drugs
ginsenotriol disuccinate sodium
03
Conditions
acute ischemic stroke (AIS)
Beyond the preview
Go deeper on NCT05745311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05745311.